HomeSAGE • NASDAQ
add
SAGE Therapeutics Inc
Previous close
$7.18
Day range
$7.02 - $7.18
Year range
$4.62 - $23.19
Market cap
430.66M USD
Avg Volume
2.43M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.82M | -83.56% |
Operating expense | 38.08M | 8.90% |
Net income | -95.78M | -192.85% |
Net profit margin | -747.33 | -1,681.48% |
Earnings per share | -1.20 | -118.15% |
EBITDA | -80.21M | -91.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 504.42M | -33.03% |
Total assets | 547.22M | -37.98% |
Total liabilities | 82.13M | -0.74% |
Total equity | 465.09M | — |
Shares outstanding | 61.48M | — |
Price to book | 0.95 | — |
Return on assets | -34.34% | — |
Return on capital | -38.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -95.78M | -192.85% |
Cash from operations | -66.56M | 44.31% |
Cash from investing | 46.57M | 10.73% |
Cash from financing | -2.00K | 99.24% |
Net change in cash | -19.99M | 74.28% |
Free cash flow | -21.73M | 81.95% |
About
Founded
2010
Website
Employees
353
